BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
81.02-0.73 (-0.89%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close81.75
Bid73.00 x 100
Ask93.50 x 100
Day's Range80.30 - 83.39
52wk Range62.12 - 118.48
1y Target EstN/A
Market Cap13.84B
P/E Ratio (ttm)-24.65
Avg Vol (3m)1,399,044
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Associated Press15 hours ago

    BioMarin reports 3Q loss

    The San Rafael, California-based company said it had a loss of 26 cents per share. Earnings, adjusted for one-time gains and costs, were 1 cent per share. The results surpassed Wall Street expectations. ...

  • GlobeNewswire16 hours ago

    BioMarin Announces Third Quarter 2016 Financial Results

    -Third Quarter 2016 Total BioMarin Revenues Increase 34% Year over Year to $280 million. -Vimizim Net Product Revenues Increase 25% Year over Year to $81 million in the Third Quarter 2016. -Kuvan Net Product ...

  • Alexion (ALXN) Q3 Earnings Lag, Revenues Tops; Lifts View
    Zacks16 hours ago

    Alexion (ALXN) Q3 Earnings Lag, Revenues Tops; Lifts View

    Alexion's (ALXN) third-quarter 2016 earnings of $1.03 cents per share missed the Zacks Consensus Estimate of $1.04.